Cargando…
Safety and efficacy of intrarenal arterial autologous CD34+ cell transfusion in patients with chronic kidney disease: A randomized, open‐label, controlled phase II clinical trial
BACKGROUND: This was a randomized, open‐label, controlled phase II clinical trial to investigate the safety, efficacy, and outcomes of intrarenal artery infusion of autologous peripheral‐blood‐derived CD34+ cells for patients with chronic kidney disease (CKD; ie, stage III or IV). MATERIALS AND METH...
Autores principales: | Yang, Chih‐Chao, Sung, Pei‐Hsun, Cheng, Ben‐Chung, Li, Yi‐Chen, Chen, Yi‐Ling, Lee, Mel S., Yip, Hon‐Kan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381811/ https://www.ncbi.nlm.nih.gov/pubmed/32297703 http://dx.doi.org/10.1002/sctm.19-0409 |
Ejemplares similares
-
Intracoronary Injection of Autologous CD34+ Cells Improves One-Year Left Ventricular Systolic Function in Patients with Diffuse Coronary Artery Disease and Preserved Cardiac Performance—A Randomized, Open-Label, Controlled Phase II Clinical Trial
por: Sung, Pei-Hsun, et al.
Publicado: (2020) -
Investigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trial
por: Lee, Mel S., et al.
Publicado: (2017) -
Intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat
por: Yue, Ya, et al.
Publicado: (2022) -
Baseline factors identified for the prediction of good responders in patients with end-stage diffuse coronary artery disease undergoing intracoronary CD34+ cell therapy
por: Sung, Pei-Hsun, et al.
Publicado: (2020) -
Correlation between Therapeutic Efficacy of CD34(+) Cell Treatment and Directed In Vivo Angiogenesis in Patients with End-Stage Diffuse Coronary Artery Disease
por: Huang, Tien-Hung, et al.
Publicado: (2018)